Therapeutic potential of TRPM8 antagonists in prostate cancer
Open Access
- 1 December 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-16
Abstract
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate cancer, although its mechanism of action remains unclear. Here, we have characterized and investigated the effects of TRPM8 modulators in prostate cancer aggressiveness disclosing the molecular mechanism underlying their biological activity. Patch-clamp and calcium fluorometric assays were used to characterize the synthesized compounds. Androgen-stimulated prostate cancer-derived cells were challenged with the compounds and the DNA synthesis was investigated in a preliminary screening. The most effective compounds were then employed to inhibit the pro-metastatic behavior of in various PC-derived cells, at different degree of malignancy. The effect of the compounds was then assayed in prostate cancer cell-derived 3D model and the molecular targets of selected compounds were lastly identified using transcriptional and non-transcriptional reporter assays. TRPM8 antagonists inhibit the androgen-dependent prostate cancer cell proliferation, migration and invasiveness. They are highly effective in reverting the androgen-induced increase in prostate cancer cell spheroid size. The compounds also revert the proliferation of castrate-resistant prostate cancer cells, provided they express the androgen receptor. In contrast, no effects were recorded in prostate cancer cells devoid of the receptor. Selected antagonists interfere in non-genomic androgen action and abolish the androgen-induced androgen receptor/TRPM8 complex assembly as well as the increase in intracellular calcium levels in prostate cancer cells. Our results shed light in the processes controlling prostate cancer progression and make the transient receptor potential melastatin-8 as a ‘druggable’ target in the androgen receptor-expressing prostate cancers.Keywords
This publication has 67 references indexed in Scilit:
- Excitation and Modulation of TRPA1, TRPV1, and TRPM8 Channel-expressing Sensory Neurons by the Pruritogen ChloroquineJournal of Biological Chemistry, 2013
- TRPM8 Ion Channels Differentially Modulate Proliferation and Cell Cycle Distribution of Normal and Cancer Prostate CellsPLOS ONE, 2012
- Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A AssociationPLOS ONE, 2011
- Estrogen regulation of TRPM8 expression in breast cancer cellsBMC Cancer, 2010
- Regulation of the Epithelial Mg2+ Channel TRPM6 by Estrogen and the Associated Repressor Protein of Estrogen Receptor Activity (REA)Journal of Biological Chemistry, 2009
- HGF/SF and menthol increase human glioblastoma cell calcium and migrationBiochemical and Biophysical Research Communications, 2008
- Non-genomic actions of androgensFrontiers in Neuroendocrinology, 2008
- Calcium and cancer: targeting Ca2+ transportNature Reviews Cancer, 2007
- Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and functionJournal of Clinical Investigation, 2007
- Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17β receptor. role of Ca2+-Calmodulin in the activation of hormone binding sitesJournal of Steroid Biochemistry, 1984